Matches in Wikidata for { <http://www.wikidata.org/entity/Q90046745> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q90046745 description "article scientifique publié en 2019" @default.
- Q90046745 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q90046745 description "scientific article published on 01 April 2019" @default.
- Q90046745 description "wetenschappelijk artikel" @default.
- Q90046745 description "наукова стаття, опублікована 1 квітня 2019" @default.
- Q90046745 name "A phase II trial of tepotinib in patients with non-small cell lung cancer (NSCLC) harboring MET alterations: The VISION study" @default.
- Q90046745 name "A phase II trial of tepotinib in patients with non-small cell lung cancer (NSCLC) harboring MET alterations: The VISION study" @default.
- Q90046745 type Item @default.
- Q90046745 label "A phase II trial of tepotinib in patients with non-small cell lung cancer (NSCLC) harboring MET alterations: The VISION study" @default.
- Q90046745 label "A phase II trial of tepotinib in patients with non-small cell lung cancer (NSCLC) harboring MET alterations: The VISION study" @default.
- Q90046745 prefLabel "A phase II trial of tepotinib in patients with non-small cell lung cancer (NSCLC) harboring MET alterations: The VISION study" @default.
- Q90046745 prefLabel "A phase II trial of tepotinib in patients with non-small cell lung cancer (NSCLC) harboring MET alterations: The VISION study" @default.
- Q90046745 P1433 Q90046745-E78FE83C-A3EE-43A7-8223-0BC36A96884D @default.
- Q90046745 P1476 Q90046745-B99CAFB0-A74B-4BD2-B8B9-9F293E4A6231 @default.
- Q90046745 P2093 Q90046745-05C8A4EB-99FF-4814-9D18-53CBCE853DEC @default.
- Q90046745 P2093 Q90046745-28DF6F34-1507-44A6-9F90-BC56B28B19FB @default.
- Q90046745 P2093 Q90046745-2EAF4A1B-54C4-4A63-845A-7C6F8E619C90 @default.
- Q90046745 P2093 Q90046745-44194212-8EC0-4AB1-B66F-12713AFEB530 @default.
- Q90046745 P2093 Q90046745-59668DD6-9503-48F6-BFE3-265863C1396B @default.
- Q90046745 P2093 Q90046745-99E51478-AC80-4CDE-9E8E-A4461B97F68C @default.
- Q90046745 P2093 Q90046745-9F69CDD9-FB25-477B-8239-ABAE58EA9319 @default.
- Q90046745 P2093 Q90046745-DADBFA06-8D62-4115-A24D-42877A005F8B @default.
- Q90046745 P2093 Q90046745-DFE2A90C-B3FE-4B21-BC79-5D89EAB49F32 @default.
- Q90046745 P2093 Q90046745-E62BF069-0126-42E5-8258-232E95EF8F0A @default.
- Q90046745 P2093 Q90046745-F69A657A-8681-4100-80C1-3E799BA9CBA1 @default.
- Q90046745 P304 Q90046745-76F82C95-4EE9-49AD-B6FB-7D4E815311C9 @default.
- Q90046745 P31 Q90046745-4A95AFD3-718A-4F23-A478-9599F3E01C84 @default.
- Q90046745 P356 Q90046745-4911137D-4377-4A77-A607-88D2951DAE85 @default.
- Q90046745 P478 Q90046745-E933B067-4766-4B8F-860A-A6593D75692E @default.
- Q90046745 P577 Q90046745-28130745-AF6C-4BF6-8895-C06DD987D090 @default.
- Q90046745 P921 Q90046745-6AF5C9D7-FAC5-43CB-881B-F865D01DBC0F @default.
- Q90046745 P921 Q90046745-FC232477-9240-4383-8BB4-4FED60B8B03D @default.
- Q90046745 P356 MDZ063.080 @default.
- Q90046745 P1433 Q326122 @default.
- Q90046745 P1476 "A phase II trial of tepotinib in patients with non-small cell lung cancer (NSCLC) harboring MET alterations: The VISION study" @default.
- Q90046745 P2093 "A Cortot" @default.
- Q90046745 P2093 "E Felip" @default.
- Q90046745 P2093 "F Griesinger" @default.
- Q90046745 P2093 "H Sakai" @default.
- Q90046745 P2093 "J Mazieres" @default.
- Q90046745 P2093 "J Scheele" @default.
- Q90046745 P2093 "J Straub" @default.
- Q90046745 P2093 "L Horn" @default.
- Q90046745 P2093 "P Paik" @default.
- Q90046745 P2093 "R Bruns" @default.
- Q90046745 P2093 "R Veillon" @default.
- Q90046745 P304 "ii66" @default.
- Q90046745 P31 Q13442814 @default.
- Q90046745 P356 "10.1093/ANNONC/MDZ063.080" @default.
- Q90046745 P478 "30 Suppl 2" @default.
- Q90046745 P577 "2019-04-01T00:00:00Z" @default.
- Q90046745 P921 Q3658562 @default.
- Q90046745 P921 Q42824440 @default.